These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26174150)

  • 21. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P; Wu X; Chen W; Liu J; Wang X
    Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced Serum Level of Interleukin-10 is Associated with Cerebral Infarction: A Case-Control and Meta-Analysis Study.
    Zhu Y; Yang H; Diao Z; Li Y; Yan C
    Mol Neurobiol; 2016 May; 53(4):2698-704. PubMed ID: 26253723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased serum resistin levels correlate with psoriasis: a meta-analysis.
    Huang H; Shen E; Tang S; Tan X; Guo X; Wang Q; Ding H
    Lipids Health Dis; 2015 May; 14():44. PubMed ID: 25980409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of apparent diffusion coefficient (ADC) in assessing radiotherapy and chemotherapy success in cervical cancer.
    Fu ZZ; Peng Y; Cao LY; Chen YS; Li K; Fu BH
    Magn Reson Imaging; 2015 Jun; 33(5):516-24. PubMed ID: 25660642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum.
    De La Franier B; Thompson M
    Biosensors (Basel); 2020 Feb; 10(2):. PubMed ID: 32075013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of lysophosphatidic acid in cerebrospinal fluid and plasma of patients with schizophrenia.
    Gotoh L; Yamada M; Hattori K; Sasayama D; Noda T; Yoshida S; Kunugi H; Yamada M
    Psychiatry Res; 2019 Mar; 273():331-335. PubMed ID: 30682553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses.
    Xiao Y; Chen Y; Kennedy AW; Belinson J; Xu Y
    Ann N Y Acad Sci; 2000 Apr; 905():242-59. PubMed ID: 10818458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and Characterization of a Dual-Protein Strategy for an Early-Stage Assay of Ovarian Cancer Biomarker Lysophosphatidic Acid.
    Davoudian K; Spagnolo S; Lotay N; Satkauskas M; Mészáros G; Hianik T; Keresztes Z; Walker G; Thompson M
    Biosensors (Basel); 2024 Jun; 14(6):. PubMed ID: 38920591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic Tailoring of Electrostatic and Hydrophobic Interactions for Rapid and Specific Recognition of Lysophosphatidic Acid, an Early-Stage Ovarian Cancer Biomarker.
    Wang Y; Pei H; Jia Y; Liu J; Li Z; Ai K; Lu Z; Lu L
    J Am Chem Soc; 2017 Aug; 139(33):11616-11621. PubMed ID: 28782946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity.
    Hosogaya S; Yatomi Y; Nakamura K; Ohkawa R; Okubo S; Yokota H; Ohta M; Yamazaki H; Koike T; Ozaki Y
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):364-8. PubMed ID: 18583620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kishimoto T; Miyazaki T; Nishino A; Nakajima N; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Yatomi Y; Daida H
    Clin Chim Acta; 2012 Jan; 413(1-2):207-12. PubMed ID: 21983165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
    Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
    Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between Homocysteine and Cerebral Small Vessel Disease: A Meta-Analysis.
    Piao X; Wu G; Yang P; Shen J; De A; Wu J; Qu Q
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2423-2430. PubMed ID: 29801814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
    Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
    Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of osteoarthritis and circulating adiponectin levels: a systematic review and meta-analysis.
    Tang Q; Hu ZC; Shen LY; Shang P; Xu HZ; Liu HX
    Lipids Health Dis; 2018 Aug; 17(1):189. PubMed ID: 30115130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
    Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of increased leptin expression in osteoarthritis patients.
    Zhang P; Zhong ZH; Yu HT; Liu B
    PLoS One; 2015; 10(4):e0123224. PubMed ID: 25893833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of acetylsalicylate on plasma lysophosphatidic acid level in patients with ischemic cerebral vascular diseases.
    Li ZG; Yu ZC; Wang DZ; Ju WP; Zhan X; Wu QZ; Wu XJ; Cong HM; Man HH
    Neurol Res; 2008 May; 30(4):366-9. PubMed ID: 18544253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between C-reactive protein level and subsequent risk of ovarian cancer: A meta-analysis of 13 cohorts in 1,852 ovarian cancer patients.
    Wang Y; Zhang Z; Wang J; Zhang X
    Medicine (Baltimore); 2020 Jan; 99(5):e18821. PubMed ID: 32000385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and Inconsistencies in Using Lysophosphatidic Acid as a Biomarker for Ovarian Cancer.
    Yagi T; Shoaib M; Kuschner C; Nishikimi M; Becker LB; Lee AT; Kim J
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30979045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.